Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Corvus Pharmaceuticals (CRVS) Shares Issued: 2023-2025

Historic Shares Issued for Corvus Pharmaceuticals (CRVS) over the last 1 years, with Jun 2025 value amounting to $35.5 million.

  • Corvus Pharmaceuticals' Shares Issued was N/A to $35.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $38.3 million, marking a year-over-year change of. This contributed to the annual value of $18.6 million for FY2024, which is 137.03% up from last year.
  • According to the latest figures from Q2 2025, Corvus Pharmaceuticals' Shares Issued is $35.5 million, which was up 12,611.83% from $279,000 recorded in Q1 2025.
  • Over the past 5 years, Corvus Pharmaceuticals' Shares Issued peaked at $35.5 million during Q2 2025, and registered a low of $4,000 during Q1 2023.
  • For the 3-year period, Corvus Pharmaceuticals' Shares Issued averaged around $7.6 million, with its median value being $1.3 million (2023).